References
- Seggewiss R, Lore K, Greiner E, Magnusson M K, Price D A, Douek D C, et al. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood 2005; 105: 2473–2479
- Mumprecht S, Matter M, Pavelic V, Ochsenbein A F. Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections. Blood 2006; 108: 3406–3413
- Mattiuzzi G N, Cortes J E, Talpaz M, Reuben J, Rios M B, Shan J, et al. Development of Varicella-Zoster virus infection in patients with chronic myelogenous leukemia treated with imatinib mesylate. Clin Cancer Res 2003; 9: 976–980
- Ikeda K, Shiga Y, Takahashi A, Kai T, Kimura H, Takeyama K, et al. Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment. Leuk Lymphoma 2006; 47: 155–157
- Brenchley J M, Karandikar N J, Betts M R, Ambrozak D R, Hill B J, Crotty L E, et al. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 2003; 101: 2711–2720
- Zerr D M, Meier A S, Selke S S, Frenkel L M, Huang M L, Wald A, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med 2005; 352: 768–776
- Dockrell D H, Paya C V. Human herpesvirus-6 and -7 in transplantation. Rev Med Virol 2001; 11: 23–36
- Hall C B, Long C E, Schnabel K C, Caserta M T, McIntyre K M, Costanzo M A, et al. Human herpes virus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 1994; 331: 432–438
- Cone R W, Hackman R C, Huamg M L, Bowden R A, Meyers J D, Metcalf M, et al. Human herpesvirus 6 in lung tissue from patients with neumonitis after bone marrow transplantation. N Engl J Med 1993; 329: 156–161
- Aandahl E M, Sandberg J K, Beckerman K P, Tasken K, Moretto W J, Nixon D F. CD7 is a differentiation marker that identifies multiple CD8 T cell effector subsets. J Immunol 2003; 170: 2349–2355
- Aandahl E M, Quigley M F, Moretto W J, Moll M, Gonzalez V D, Sonnerborg A, et al. Expansion of CD7(low) and CD7(negative) CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood 2004; 104: 3672–3678
- Anderson L J. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987; 6: 711–718